Medicine and Dentistry
Bloodstream Infection
100%
Odds Ratio
52%
Catheter Removal
47%
Central Venous Catheter
46%
Acinetobacter Baumannii
43%
Carbapenem
36%
Antibiotic Therapy
31%
Mantoux Test
28%
Spondylitis
27%
Extrapulmonary Tuberculosis
25%
Hematopoietic Stem Cell Transplantation
25%
Methicillin Resistant Staphylococcus Aureus
21%
Catheter Infection
20%
Comorbidity
19%
Recurrent Disease
18%
Observational Study
18%
Candidemia
17%
Acinetobacter
17%
Sequela
17%
Staphylococcal Bacteremia
17%
Charlson Comorbidity Index
17%
Burkholderia Cepacia Complex
17%
Cystic Fibrosis
17%
Pneumocystis Jirovecii
17%
Cytomegalovirus Infection
17%
Colistimethate
17%
Prognostic Factor
16%
Septic Shock
15%
Cytomegalovirus
14%
Blood Culture
13%
Pneumocystis Pneumonia
12%
Meropenem
11%
Acute Kidney Injury
11%
Mixed Infection
11%
Chlorhexidine
10%
Pathogen
10%
Liver Cirrhosis
10%
Kidney Transplantation
10%
Vancomycin
9%
Solid Organ Transplantation
9%
T Cell
9%
Mortality Rate
9%
Hepatitis A
8%
Clostridium Difficile Infection
8%
Gamma Interferon
8%
Organizing Pneumonia
8%
Herpes Simplex Virus
8%
COVID-19
8%
Human Immunodeficiency Virus Infection
8%
Differential Diagnosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
81%
Carbapenem
37%
Observational Study
35%
Acinetobacter Baumannii
34%
Extrapulmonary Tuberculosis
25%
Antibiotics
23%
Methicillin Resistant Staphylococcus Aureus Infection
20%
Staphylococcus Aureus
18%
Spondylitis
18%
Burkholderia Cepacia Complex
17%
Tuberculous Meningitis
17%
Cystic Fibrosis
17%
Staphylococcal Bacteremia
17%
Colistimethate
17%
Tuberculin
17%
Prevalence
15%
Antibiotic Therapy
15%
Methicillin-Resistant Staphylococcus Aureus
12%
Recurrent Disease
12%
Quinolone Derivative
11%
Vancomycin
11%
Infectious Agent
11%
Respiratory Virus
10%
Liver Cirrhosis
10%
Mortality Rate
10%
Acute Kidney Failure
9%
Levofloxacin
8%
Linezolid
8%
Respiratory Tract Disease
8%
Organizing Pneumonia
8%
Atypical Mycobacterium
8%
Cytomegalovirus Infection
8%
Acute Graft Rejection
8%
Gamma Interferon
8%
Virus Meningitis
8%
Glycopeptide
8%
Antimicrobial Therapy
8%
Adalimumab
8%
Mucormycosis
8%
Zabofloxacin
8%
Community Acquired Pneumonia
8%
Streptococcus Pneumonia
8%
Meticillin
8%
Health Care Associated Pneumonia
6%
Human Respiratory Syncytial Virus
5%
Implant
5%
Immunology and Microbiology
Methicillin-Resistant Staphylococcus Aureus
54%
Mortality Rate
18%
Infectious Agent
17%
Comorbidity
17%
Pneumocystis
17%
Pneumocystis Jiroveci
17%
Minimum Inhibitory Concentration
14%
Respiratory Virus
12%
Staphylococcus Aureus
12%
Enterobacteriaceae
11%
Chlorhexidine
10%
Human Respiratory Syncytial Virus
10%
Biofilm
9%
Immunocompromised Patient
8%
Colistin
8%
Inhibitory Concentration
8%
Computer Assisted Tomography
8%
Empyema
8%
Cladosporium
8%
Mantoux Test
8%
Granulomatosis with Polyangiitis
8%
Virus Detection
8%
Solid Organ Transplantation
8%
Bifidobacterium
8%
Acinetobacter Baumannii
8%
Inflammatory Arthritis
8%
Human Immunodeficiency Virus Infection
8%
Reverse Transcription Polymerase Chain Reaction
8%
Back Muscle
8%
Mupirocin
8%
Pulmonary Inflammation
8%
Gram-Negative Bacteria
8%
Vancomycin-Resistant Enterococcus
8%
Cell Wall
8%
Glycopeptide
8%
Nontuberculous mycobacteria
8%
Prevalence
7%
Human Metapneumovirus
5%
Antibiotic Sensitivity
5%
Methicillin Susceptible Staphylococcus Aureus
5%
